Publications are listed according to year, with the most recent first. Within each year, publications are listed in alphabetical order, based on the first author’s surname. Click on “Publication link” to access the publication on PubMed. Use the search box above to find particular publications based on author or terms in the title.
Epigenetic manipulation of the immune response: a novel treatment strategy in hematologic malignancies
Cytotherapy. 2011 May;13(5):516-7.
Advances in the cellular and molecular biology of angiogenesis.
Egginton S, Bicknell R.
Biochem Soc Trans. 2011 Dec;39(6):1551-5.
Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13.
Gabitass RF, Annels NE, Stocken DD, Pandha HA, Middleton GW.
Cancer Immunol Immunother. 2011 Oct;60(10):1419-30.
Coexistence of LMPP-like and GMP-like leukemia stem cells in acute myeloid leukemia
Goardon N, Marchi E, Atzberger A, Quek L, Schuh A, Soneji S, Woll P, Mead A, Alford KA, Rout R, Chaudhury S, Gilkes A, Knapper S, Beldjord K, Begum S, Rose S, Geddes N, Griffiths M, Standen G, Sternberg A, Cavenagh J, Hunter H, Bowen D, Killick S, Robinson L, Price A, Macintyre E, Virgo P, Burnett A, Craddock C, Enver T, Jacobsen SE, Porcher C, Vyas P.
Cancer Cell. 2011 Jan 18;19(1):138-52.
Dominant responses with conservation of T-cell receptor usage in the CD8+ T-cell recognition of a cancer testis antigen peptide presented through HLA-Cw7 in patients with multiple myeloma
Goodyear OC, Pearce H, Pratt G, Moss P.
Cancer Immunol Immunother. 2011 Dec;60(12):1751-61.
Bioinformatic methods for finding differentially expressed genes in cDNA libraries, applied to the identification of tumour vascular targets.
Herbert JM, Stekel DJ, Mura M, Sychev M, Bicknell R.
Methods Mol Biol. 2011;729:99-119.